Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

Medicine and Dentistry

• Nusinersen 100%
• Child 50%
• Least Square Analysis 40%
• Spinal Muscular Atrophy 40%
• Motor Performance 20%
• Interim Analysis 20%
• Analysis 20%
• Therapeutic Procedure 20%
• Adverse Event 10%
• Age 10%
• Skill 10%
• Drug 10%
• Intrathecal Drug Administration 10%
• Sham Procedure 10%
• Gene 10%
• Chemotherapeutic Agent 10%
• Recombinant Gamma Interferon 10%
• Antisense Oligonucleotide 10%
• Symptom 10%
• RNA Splicing 10%
• Messenger RNA Precursor 10%
• Incidence 10%
• Survival 10%
• Amaurosis 10%
• Motor Neuron 10%